Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus.

[1]  Fan Zhang,et al.  Long non-coding RNA ZFAS1 regulates the malignant progression of gastric cancer via the microRNA-200b-3p/Wnt1 axis , 2019, Bioscience, biotechnology, and biochemistry.

[2]  C. Bao,et al.  Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients , 2019, Cellular & Molecular Immunology.

[3]  H. Xiong,et al.  Ligation of CD180 contributes to endotoxic shock by regulating the accumulation and immunosuppressive activity of myeloid-derived suppressor cells through STAT3. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[4]  M. Weisman,et al.  A promising approach to targeting type 1 IFN in systemic lupus erythematosus , 2019, The Journal of clinical investigation.

[5]  M. Crow,et al.  Type I Interferons in Autoimmune Disease. , 2019, Annual review of pathology.

[6]  L. Magder,et al.  Association between changes in gene signatures expression and disease activity among patients with systemic lupus erythematosus , 2019, BMC Medical Genomics.

[7]  C. Xia,et al.  Phenotypic and Functional Diversities of Myeloid-Derived Suppressor Cells in Autoimmune Diseases , 2018, Mediators of inflammation.

[8]  L. Lai,et al.  An autoimmune disease variant of IgG1 modulates B cell activation and differentiation , 2018, Science.

[9]  G. Gibson,et al.  Distinct Effector B Cells Induced by Unregulated Toll‐like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus , 2018, Immunity.

[10]  R. Rad,et al.  Myeloid-derived suppressor cells control B cell accumulation in the CNS during autoimmunity , 2018, Nature Immunology.

[11]  Liang-liang Hui,et al.  NEAT1 contributes to ox‐LDL‐induced inflammation and oxidative stress in macrophages through inhibiting miR‐128 , 2018, Journal of cellular biochemistry.

[12]  B. Rovin,et al.  B-cell therapy in lupus nephritis: an overview. , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  S. Shen,et al.  Inhibition of lncRNA NEAT1 suppresses the inflammatory response in IBD by modulating the intestinal epithelial barrier and by exosome-mediated polarization of macrophages. , 2018, International journal of molecular medicine.

[14]  B. Rovin,et al.  Peripheral Blood B Cell Depletion after Rituximab and Complete Response in Lupus Nephritis. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[15]  J. Gottenberg,et al.  The 2018 pipeline of targeted therapies under clinical development for Systemic Lupus Erythematosus: a systematic review of trials. , 2018, Autoimmunity reviews.

[16]  Z. Yao,et al.  lincRNA-Cox2 regulates NLRP3 inflammasome and autophagy mediated neuroinflammation , 2018, Cell Death & Differentiation.

[17]  M. Baniyash,et al.  Plasticity and biological diversity of myeloid derived suppressor cells. , 2018, Current opinion in immunology.

[18]  T. Niewold,et al.  Type I interferon in rheumatic diseases , 2018, Nature Reviews Rheumatology.

[19]  G. Sun,et al.  Long non-coding RNA NEAT1 regulates the proliferation, migration and invasion of gastric cancer cells via targeting miR-335-5p/ROCK1 axis. , 2018, Die Pharmazie.

[20]  Weiping Chen,et al.  KIF9-AS1, LINC01272 and DIO3OS lncRNAs as novel biomarkers for inflammatory bowel disease , 2017, Molecular medicine reports.

[21]  L. Arnaud,et al.  Targeting interferons and their pathways in systemic lupus erythematosus. , 2017, Autoimmunity reviews.

[22]  Howard Y. Chang,et al.  Gene regulation in the immune system by long noncoding RNAs , 2017, Nature Immunology.

[23]  O. Schwartz,et al.  HEXIM1 and NEAT1 Long Non-coding RNA Form a Multi-subunit Complex that Regulates DNA-Mediated Innate Immune Response. , 2017, Molecular cell.

[24]  Jun Li,et al.  The long non-coding RNA SNHG3 functions as a competing endogenous RNA to promote malignant development of colorectal cancer , 2017, Oncology reports.

[25]  S. Bolland,et al.  Expanding the B Cell-Centric View of Systemic Lupus Erythematosus. , 2017, Trends in immunology.

[26]  Robert W. Hoffman,et al.  Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab , 2016, Arthritis & rheumatology.

[27]  D. Gabrilovich.  Myeloid-Derived Suppressor Cells , 2017, Cancer Immunology Research.

[28]  Lingling Wu,et al.  Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus. , 2016, Journal of autoimmunity.

[29]  Surajit Das,et al.  B cell activating factor is induced by toll-like receptor and NOD-like receptor-ligands and plays critical role in IgM synthesis in Labeo rohita. , 2016, Molecular immunology.

[30]  J. Xu,et al.  Myeloid-derived suppressor cells contribute to systemic lupus erythaematosus by regulating differentiation of Th17 cells and Tregs. , 2016, Clinical science.

[31]  Min-jung Park,et al.  Myeloid‐Derived Suppressor Cells Induce the Expansion of Regulatory B Cells and Ameliorate Autoimmunity in the Sanroque Mouse Model of Systemic Lupus Erythematosus , 2016, Arthritis & rheumatology.

[32]  Zhong-Gao Xu,et al.  Arginase-1–dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus , 2016, Science Translational Medicine.

[33]  M. Glymenaki,et al.  Elimination of Granulocytic Myeloid‐Derived Suppressor Cells in Lupus‐Prone Mice Linked to Reactive Oxygen Species–Dependent Extracellular Trap Formation , 2015, Arthritis & rheumatology.

[34]  M. You,et al.  STS‐1 promotes IFN‐α induced autophagy by activating the JAK1‐STAT1 signaling pathway in B cells , 2015, European journal of immunology.

[35]  M. You,et al.  17β-estradiol contributes to the accumulation of myeloid-derived suppressor cells in blood by promoting TNF-α secretion. , 2015, Acta biochimica et biophysica Sinica.

[36]  M. Tremblay,et al.  HIV-1–Triggered Release of Type I IFN by Plasmacytoid Dendritic Cells Induces BAFF Production in Monocytes , 2015, The Journal of Immunology.

[37]  Juan Li,et al.  Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis , 2014, Annals of the rheumatic diseases.

[38]  J. Dou,et al.  Activation-induced necroptosis contributes to B-cell lymphopenia in active systemic lupus erythematosus , 2014, Cell Death and Disease.

[39]  P. Schneider,et al.  The BAFF/APRIL system in SLE pathogenesis , 2014, Nature Reviews Rheumatology.

[40]  D. Elbirt,et al.  Type I interferon signature in systemic lupus erythematosus. , 2014, The Israel Medical Association journal : IMAJ.

[41]  T. Niewold,et al.  Nucleic Acid Sensors and Type I Interferon Production in Systemic Lupus Erythematosus , 2013, Front. Immunol..

[42]  L. Davis,et al.  SLE Peripheral Blood B Cell, T Cell and Myeloid Cell Transcriptomes Display Unique Profiles and Each Subset Contributes to the Interferon Signature , 2013, PloS one.

[43]  K. Jeang,et al.  NEAT1 Long Noncoding RNA and Paraspeckle Bodies Modulate HIV-1 Posttranscriptional Expression , 2013, mBio.

[44]  J. Darnell,et al.  The JAK-STAT pathway at twenty. , 2012, Immunity.

[45]  M. Cancro,et al.  Role of type I interferons in the activation of autoreactive B cells , 2012, Immunology and cell biology.

[46]  T. Mituyama,et al.  MENε/β noncoding RNAs are essential for structural integrity of nuclear paraspeckles , 2009, Proceedings of the National Academy of Sciences.

[47]  M. Shlomchik,et al.  Autoreactive B Cells Discriminate CpG-Rich and CpG-Poor DNA and This Response Is Modulated by IFN-α1 , 2008, The Journal of Immunology.

[48]  L. Rönnblom,et al.  Possible induction of systemic lupus erythematosus by interferon‐α treatment in a patient with a malignant carcinoid tumour , 1990, Journal of internal medicine.

[49]  Gregory F. Wu,et al.  Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis , 2016, Acta Neuropathologica.

[50]  S. Fukuyama,et al.  Systemic lupus erythematosus after alpha-interferon therapy for chronic hepatitis C: a case report and review of the literature. , 2000, The American journal of gastroenterology.

[51]  S. Fukuyama,et al.  Systemic Lupus Erythematosus After α-Interferon Therapy for Chronic Hepatitis C: A Case Report and Review of the Literature , 2000, American Journal of Gastroenterology.